Postbiotic modulation of retinoic acid imprinted mucosal-like dendritic cells by probiotic Lactobacillus reuteri 17938 in vitro

Frontiers in Immunology

Volumn 7, Issue MAR, 2016, Pages

  Haileselassie, Yeneneh ^a   Navis, Marit ^a   Vu, Nam ^a   Qazi, Khaleda Rahman ^a   Rethi, Bence ^b   Sverremark Ekström, Eva ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dendritic cells; Lactobacillus reuteri; Postbiotics; Probiotics; Retinoic acid

Indexed keywords

CD103 ANTIGEN; CD1D ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR7; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 3; PROBIOTIC AGENT; RETINOIC ACID; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RELB; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENOME IMPRINTING; LACTOBACILLUS REUTERI; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84964680370     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00096     Document Type: Article

References (51)

1. Rescigno M. Dendritic cell-epithelial cell crosstalk in the gut. Immunol Rev (2014) 260(1):118-28. doi:10.1111/imr.12181.
2. Lampen A, Meyer S, Arnhold T, Nau H. Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes. J Pharmacol Exp Ther (2000) 295(3):979-85.
3. Zeng R, Oderup C, Yuan R, Lee M, Habtezion A, Hadeiba H, et al. Retinoic acid regulates the development of a gut-homing precursor for intestinal dendritic cells. Mucosal Immunol (2013) 6(4):847-56. doi:10.1038/mi.2012.123.
4. Iliev ID, Spadoni I, Mileti E, Matteoli G, Sonzogni A, Sampietro GM, et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut (2009) 58(11):1481-9. doi:10.1136/gut.2008.175166.
5. Coombes JL, Siddiqui KRR, Arancibia-Carcamo CV, Hall J, Sun C-M, Belkaid Y, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF- and retinoic acid dependent mechanism. J Exp Med (2007) 204(8):1757-64. doi:10.1084/jem.20070590.
6. Bakdash G, Vogelpoel LT, van Capel TM, Kapsenberg ML, de Jong EC. Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells. Mucosal Immunol (2015) 8(2):265-78. doi:10.1038/mi.2014.64.
7. Walter J. Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Appl Environ Microbiol (2008) 74(16):4985-96. doi:10.1128/AEM.00753-08.
8. Wells JM. Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact (2011) 10(Suppl 1):S17. doi:10.1186/1475-2859-10-S1-S17.
9. Remus DM, Kleerebezem M, Bron PA. An intimate tête-à-tête - how probiotic lactobacilli communicate with the host. Eur J Pharmacol (2011) 668:S33-42. doi:10.1016/j.ejphar.2011.07.012.
10. Liu Y, Fatheree NY, Mangalat N, Rhoads JM. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol (2010) 299(5):1087-96. doi:10.1152/ajpgi.00124.2010.
11. Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther (2006) 4:261-75. doi:10.1586/14787210.4.2.261.
12. Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet (2013) 382(9900):1249-57. doi:10.1016/S0140-6736(13)61218-0.
13. Panwar H, Rashmi HM, Batish VK, Grover S. Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives. Diabetes Metab Res Rev (2013) 29(2):103-12. doi:10.1002/dmrr.2376.
14. Vitaliti G, Pavone P, Guglielmo F, Spataro G, Falsaperla R. The immunomodulatory effect of probiotics beyond atopy: an update. J Asthma (2013) 0903(3):1-13. doi:10.3109/02770903.2013.862259.
15. Clarke G, Cryan JF, Dinan TG, Quigley EM. Review article: probiotics for the treatment of irritable bowel syndrome - focus on lactic acid bacteria. Aliment Pharmacol Ther (2012) 35(4):403-13. doi:10.1111/j.1365-2036.2011.04965.x.
16. Urbanska M, Szajewska H. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Eur J Pediatr (2014) 173(10):1327-37. doi:10.1007/s00431-014-2328-0.
17. Rosander A, Connolly E, Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol (2008) 74(19):6032-40. doi:10.1128/AEM.00991-08.
18. Liu Y, Fatheree NY, Mangalat N, Rhoads JM. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-kB signaling in the intestine. Am J Physiol Gastrointest Liver Physiol (2012) 302(6):G608-17. doi:10.1152/ajpgi.00266.2011.
19. Liu Y, Tran DQ, Fatheree NY, Rhoads JM. Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2014) 307(2):177-86. doi:10.1152/ajpgi.00038.2014.
20. Cicenia A, Scirocco A, Carabotti M, Pallotta L, Marignani M, Severi C. Postbiotic activities of lactobacilli - derived factors. J Clin Gastroenterol (2014) 48:18-22. doi:10.1097/MCG.0000000000000231.
21. Haileselassie Y, Johansson MA, Zimmer CL, Björkander S, Petursdottir DH, Dicksved J, et al. Lactobacilli regulate Staphylococcus aureus 161:2-induced pro-inflammatory T-cell responses in vitro. PLoS One (2013) 8(10):e77893. doi:10.1371/journal.pone.0077893.
22. den Hartog G, Van Altena C, Savelkoul HFJ, Van Neerven RJJ. The mucosal factors retinoic acid and TGF-β1 induce phenotypically and functionally distinct dendritic cell types. Int Arch Allergy Immunol (2013) 162(3):225-36. doi:10.1159/000353243.
23. Bain CC, Mowat AM. The monocyte-macrophage axis in the intestine. Cell Immunol (2014) 291(1-2):41-8. doi:10.1016/j.cellimm.2014.03.012.
24. Szymczak WA, Deepe GS. The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity. J Immunol (2009) 183(3):1964-74. doi:10.4049/jimmunol.0901316.
25. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell (1993) 75(2):263-74. doi:10.1016/0092-8674(93)80068-P.
26. Spencer SD, Di Marco F, Hooley J, Pitts-Meek S, Bauer M, Ryan AM, et al. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med (1998) 187(4):571-8. doi:10.1084/jem.187.4.571.
27. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 66(11):5224-31.
28. Demont A, Hacini-Rachinel F, Doucet-Ladevèze R, Ngom-Bru C, Mercenier A, Prioult G, et al. Live and heat-treated probiotics differently modulate IL10 mRNA stabilization and microRNA expression. J Allergy Clin Immunol (2015). doi:10.1016/j.jaci.2015.08.033.
29. Manuzak J, Dillon S, Wilson C. Differential interleukin-10 (IL-10) and IL-23 production by human blood monocytes and dendritic cells in response to commensal enteric bacteria. Clin Vaccine Immunol (2012) 19(8):1207-17. doi:10.1128/CVI.00282-12.
30. Cox JH, Kljavin NM, Ota N, Leonard J, Roose-Girma M, Diehl L, et al. Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice. Mucosal Immunol (2012) 5(1):99-109. doi:10.1038/mi.2011.54.
31. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol (2011) 29:71-109. doi:10.1146/annurev-immunol-031210-101312.
32. Aychek T, Mildner A, Yona S, Kim K-W, Lampl N, Reich-Zeliger S, et al. IL-23-mediated mononuclear phagocyte crosstalk protects mice from Citrobacter rodentium-induced colon immunopathology. Nat Commun (2015) 6:6525. doi:10.1038/ncomms7525.
33. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med (2008) 14(3):282-9. doi:10.1038/nm1720.
34. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 139(3):485-98. doi:10.1016/j.cell.2009.09.033.
35. Goodrich ME, McGee DW. Effect of intestinal epithelial cell cytokines on mucosal B-cell IgA secretion: enhancing effect of epithelial-derived IL-6 but not TGF-beta on IgA+ B cells. Immunol Lett (1999) 67(1):11-4. doi:10.1016/S0165-2478(98)00112-6.
36. Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol (2010) 40(7):1830-5. doi:10.1002/eji.201040391.
37. Mei J, Liu Y, Dai N, Hoffmann C, Hudock KM, Zhang P, et al. Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice. J Clin Invest (2012) 122(3):974-86. doi:10.1172/JCI60588.
38. Kotarsky K, Sitnik KM, Stenstad H, Kotarsky H, Schmidtchen A, Koslowski M, et al. A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosa. Mucosal Immunol (2010) 3(1):40-8. doi:10.1038/mi.2009.115.
39. Shea-Donohue T, Thomas K, Cody MJ, Aiping Z, Detolla LJ, Kopydlowski KM, et al. Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun (2008) 14(2):117-24. doi:10.1177/1753425908088724.
40. Cruickshank SM, Deschoolmeester ML, Svensson M, Howell G, Bazakou A, Logunova L, et al. Rapid dendritic cell mobilization to the large intestinal epithelium is associated with resistance to Trichuris muris infection. J Immunol (2009) 182(5):3055-62. doi:10.4049/jimmunol.0802749.
41. Doyen V, Rubio M, Braun D, Nakajima T, Abe J, Saito H, et al. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med (2003) 198(8):1277-83. doi:10.1084/jem.20030705.
42. Greter M, Helft J, Chow A, Hashimoto D, Mortha A, Agudo-Cantero J, et al. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity (2012) 36(6):1031-46. doi:10.1016/j.immuni.2012.03.027.
43. Van De Laar L, Coffer PJ, Woltman AM. Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy. Blood (2012) 119(15):3383-93. doi:10.1182/blood-2011-11-370130.
44. Torres-Aguilar H, Aguilar-Ruiz SR, González-Pérez G, Munguía R, Bajaña S, Meraz-Ríos MA, et al. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J Immunol (2010) 184(4):1765-75. doi:10.4049/jimmunol.0902133.
45. van der Does AM, Kenne E, Koppelaar E, Agerberth B, Lindbom L. Vitamin D3 and phenylbutyrate promote development of a human dendritic cell subset displaying enhanced antimicrobial properties. J Leukoc Biol (2014) 95(6):883-91. doi:10.1189/jlb.1013549.
46. Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol (2005) 115(6):1260-7. doi:10.1016/j.jaci.2005.03.036.
47. Steinman RM. The control of immunity and tolerance by dendritic cells. Pathol Biol (2003) 51:59-60. doi:10.1016/S0369-8114(03)00096-8.
48. Roncarolo M, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol (2007) 7(8):585-98. doi:10.1038/nri2138.
49. Raker VK, Domogalla MP, Steinbrink K. Tolerogenic dendritic cells for regulatory T cell induction in man. Front Immunol (2015) 6:569. doi:10.3389/fimmu.2015.00569.
50. Manicassamy S, Ravindran R, Deng J, Oluoch H, Denning TL, Kasturi SP, et al. TLR2 dependent induction of vitamin A metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits TH-17 mediated autoimmunity. Nat Med (2009) 15(4):401-9. doi:10.1038/nm.1925.
51. Liu Y, Fatheree NY, Dingle BM, Tran DQ, Rhoads JM. Lactobacillus reuteri DSM 17938 changes the frequency of Foxp3+ regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis. PLoS One (2013) 8(2):e56547. doi:10.1371/journal.pone.0056547.